BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7966510)

  • 1. Clinical diagnosis of substance use disorders in private psychiatric populations.
    Miller NS; Belkin BM; Gibbons R
    J Subst Abuse Treat; 1994; 11(4):387-92. PubMed ID: 7966510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of diagnoses made by psychiatric residents in a general emergency department.
    Warner MD; Peabody CA
    Psychiatr Serv; 1995 Dec; 46(12):1284-6. PubMed ID: 8590116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric comorbidity in patients with eating disorders.
    Braun DL; Sunday SR; Halmi KA
    Psychol Med; 1994 Nov; 24(4):859-67. PubMed ID: 7892354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric comorbidity in first episode schizophrenia: a 2 year, longitudinal outcome study.
    Sim K; Chua TH; Chan YH; Mahendran R; Chong SA
    J Psychiatr Res; 2006 Oct; 40(7):656-63. PubMed ID: 16904688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbid mental disorders in substance users from a single catchment area--a clinical study.
    Langås AM; Malt UF; Opjordsmoen S
    BMC Psychiatry; 2011 Feb; 11():25. PubMed ID: 21314980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual diagnosis subtypes in urban substance abuse and mental health clinics.
    Hien D; Zimberg S; Weisman S; First M; Ackerman S
    Psychiatr Serv; 1997 Aug; 48(8):1058-63. PubMed ID: 9255839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for psychopathology in the clinical practice.
    Eland-Goossensen A; van de Goor I; Garretsen H; Schudel J
    J Subst Abuse Treat; 1997; 14(6):585-91. PubMed ID: 9437632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and patterns of "dual diagnosis" among psychiatric inpatients.
    Lehman AF; Myers CP; Corty E; Thompson JW
    Compr Psychiatry; 1994; 35(2):106-12. PubMed ID: 8187473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers.
    Hasin DS; Trautman KD; Miele GM; Samet S; Smith M; Endicott J
    Am J Psychiatry; 1996 Sep; 153(9):1195-201. PubMed ID: 8780425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance of the MCMI-II, the MMPI, and Axis I discharge diagnosis in psychiatric inpatients.
    Libb JW; Murray J; Thurstin H; Alarcon RD
    J Pers Assess; 1992 Jun; 58(3):580-90. PubMed ID: 1613659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and prognostic characteristics associated with addictive comorbidity in hospitalized psychiatric patients].
    Liraud F; Verdoux H
    Encephale; 2000; 26(3):16-23. PubMed ID: 10951902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Composite International Diagnostic Interview and clinical DSM-III-R criteria checklist diagnoses.
    Janca A; Robins LN; Bucholz KK; Early TS; Shayka JJ
    Acta Psychiatr Scand; 1992 Jun; 85(6):440-3. PubMed ID: 1642126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing comorbidity in substance abusers. Computer assessment and clinical validation.
    Ross HE; Swinson R; Larkin EJ; Doumani S
    J Nerv Ment Dis; 1994 Oct; 182(10):556-63. PubMed ID: 7931203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual diagnosis in Spain.
    Gual A
    Drug Alcohol Rev; 2007 Jan; 26(1):65-71. PubMed ID: 17364838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidity in psychosis at first hospitalization.
    Strakowski SM; Tohen M; Stoll AL; Faedda GL; Mayer PV; Kolbrener ML; Goodwin DC
    Am J Psychiatry; 1993 May; 150(5):752-7. PubMed ID: 8480821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High interrater reliability for the Structured Clinical Interview for DSM-III-R Axis I (SCID-I).
    Skre I; Onstad S; Torgersen S; Kringlen E
    Acta Psychiatr Scand; 1991 Aug; 84(2):167-73. PubMed ID: 1950612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.
    Torrens M; Serrano D; Astals M; Pérez-Domínguez G; Martín-Santos R
    Am J Psychiatry; 2004 Jul; 161(7):1231-7. PubMed ID: 15229056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.